Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Jun;38(6):1374–1377. doi: 10.1128/aac.38.6.1374

Interaction of oxyimino beta-lactams with a class C beta-lactamase and a mutant with a spectrum extended to beta-lactams.

M Nukaga 1, K Tsukamoto 1, H Yamaguchi 1, T Sawai 1
PMCID: PMC188213  PMID: 8092840

Abstract

The class C beta-lactamase of Citrobacter freundii GN346 is a typical cephalosporinase comprising 361 amino acids, and substitution of the glutamic acid at position 219 in the enzyme by lysine was previously shown to broaden its substrate spectrum to oxyimino beta-lactams (K. Tsukamoto, R. Ohno, and T. Sawai, J. Bacteriol. 172:4348-4351, 1990). To clarify this spectrum extension from the kinetic point of view, the interactions of cefuroxime, ceftazidime, and aztreonam with the wild-type and mutant enzymes were analyzed. In addition to aztreonam, known as a progressive inhibitor of class C beta-lactamases, cefuroxime and ceftazidime were found to act as progressive inhibitors of the wild-type enzyme. On the other hand, only aztreonam showed weak progressive inhibition of the mutant enzyme. On the basis of kinetic parameters, a minimum scheme for interaction of the oxyimino beta-lactams with the wild-type enzyme was proposed, and the rate-limiting step of the hydrolysis of unfavorable substrates was indicated to be conversion of the stable acyl-enzyme intermediate to the unstable intermediate. In aztreonam hydrolysis by the mutant enzyme, the reaction rate at the rate-limiting step was 2,000 times that of the wild-type enzyme. These results indicate that the mutation at position 219 disturbs the stabilization of the stable intermediate.

Full text

PDF
1374

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bush K., Freudenberger J. S., Sykes R. B. Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria. Antimicrob Agents Chemother. 1982 Sep;22(3):414–420. doi: 10.1128/aac.22.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fisher J., Charnas R. L., Knowles J. R. Kinetic studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid. Biochemistry. 1978 May 30;17(11):2180–2184. doi: 10.1021/bi00604a024. [DOI] [PubMed] [Google Scholar]
  3. Fukagawa Y., Takei T., Ishikura T. Inhibition of beta-lactamase of Bacillus licheniformis 749/C by compound PS-5, a new beta-lactam antibiotic. Biochem J. 1980 Jan 1;185(1):177–185. doi: 10.1042/bj1850177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Sawai T., Kanno M., Tsukamoto K. Characterization of eight beta-lactamases of Gram-negative bacteria. J Bacteriol. 1982 Nov;152(2):567–571. doi: 10.1128/jb.152.2.567-571.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Sawai T., Yamaguchi A. Mechanism of beta-lactamase inhibition: differences between sulbactam and other inhibitors. Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4 Suppl):121S–129S. doi: 10.1016/0732-8893(89)90124-7. [DOI] [PubMed] [Google Scholar]
  6. Tsukamoto K., Ohno R., Nukaga M., Sawai T. The effect of amino acid substitution at position 219 of Citrobacter freundii cephalosporinase on extension of its substrate spectrum. Eur J Biochem. 1992 Aug 1;207(3):1123–1127. doi: 10.1111/j.1432-1033.1992.tb17150.x. [DOI] [PubMed] [Google Scholar]
  7. Tsukamoto K., Ohno R., Sawai T. Extension of the substrate spectrum by an amino acid substitution at residue 219 in the Citrobacter freundii cephalosporinase. J Bacteriol. 1990 Aug;172(8):4348–4351. doi: 10.1128/jb.172.8.4348-4351.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Tsukamoto K., Tachibana K., Yamazaki N., Ishii Y., Ujiie K., Nishida N., Sawai T. Role of lysine-67 in the active site of class C beta-lactamase from Citrobacter freundii GN346. Eur J Biochem. 1990 Feb 22;188(1):15–22. doi: 10.1111/j.1432-1033.1990.tb15365.x. [DOI] [PubMed] [Google Scholar]
  9. Waley S. G. The kinetics of substrate-induced inactivation. Biochem J. 1991 Oct 1;279(Pt 1):87–94. doi: 10.1042/bj2790087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Yamaguchi A., Hirata T., Sawai T. Kinetic studies on inactivation of Citrobacter freundii cephalosporinase by sulbactam. Antimicrob Agents Chemother. 1983 Jul;24(1):23–30. doi: 10.1128/aac.24.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Yun S. L., Suelter C. H. A simple method for calculating Km and V from a single enzyme reaction progress curve. Biochim Biophys Acta. 1977 Jan 11;480(1):1–13. doi: 10.1016/0005-2744(77)90315-1. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES